ContinueCare Hospital at Odessa Inc

What it reported doing in 2024

ContinueCare Hospital at Odessa Inc (CCHO) is a Long Term Acute Care Hospital (LTACH) that serves the needs of patients with medically complex conditions, especially those suffering from multi-system complications and needing extended recovery times, a hospital stay that is often 25 days or more. A patient is usually admitted after a short-term, acute-care hospital stay. After care in an LTACH, many patients are then able to transition from the LTACH to acute rehab, skilled nursing, or go home. Hospice care is also a post-acute treatment option for patients with a terminal disease who have a life expectancy of six months or less. As an LTACH, CCHO develops a continuum of care between the acute and long-term phases of a patient's illness. Our innovative and distinctive physician-driven approach allows us to bring new meaning to the "hospital-within-a-hospital" model. As a separate, fully licensed and staffed hospital, we are able to provide intensive and complex medical treatment to patients requiring longer lengths of stay for acute-care. We have speciality programs designed to meet the needs of long term, acutely ill patients with conditions including ventilator dependence, respiratory failure, chronic pulmonary problems, complex and severe wounds, and infections requiring long term antibiotic therapy. LTACH facilities also provide physical, occupational, speech and nutritional therapies, as well as pain management. Patients and families are invited to attend our weekly interdisciplinary team (IDT) conference where patient goals are reviewed each week. Patients and families may also request to meet with the team at a more convenient time. DURING THE FISCAL YEAR ENDED JUNE 30, 2025, CCHO'S TOTAL PATIENTS ADMITTED WERE 214 AND THE TOTAL NUMBER OF PATIENT CARE DAYS PROVIDED WAS 6,269. THE AVERAGE DAILY CENSUS WAS 17.2 PATIENTS AND THE AVERAGE LENGTH OF STAY OF THE DISCHARGED PATIENTS WAS 30.3 DAYS.

Financial Efficiency

• Mission deployment rate: 94.7%; rating input score 95
• Program expense ratio: 87.3%; rating input score 87
• Fundraising efficiency: Limited

Transparency & Controls

• Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
• Pay-setting controls: 0 of 6 controls in place; rating input score 0
  • Compensation committee: Missing
  • Independent consultant: Missing
  • Other Form 990s reviewed: Missing
  • Written employment contract: Missing
  • Compensation survey or study: Missing
  • Board or committee approval: Missing
• Foreign activity oversight: Limited
• Grant itemization coverage: Limited
• Major donor itemization: Limited
• Related-party transparency: Limited

Accountability

• Independent voting board: 80%; rating input score 80; 14th percentile among comparable filings
• Governance controls: 7 of 9 controls in place; rating input score 78
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Fail
  • Other executive compensation review process: Fail
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: -8.5%; rating input score 15; 15th percentile among comparable filings
• Total-asset coverage ratio: 0.33; rating input score 10; 10th percentile among comparable filings
• Liabilities to assets ratio: 1.49; rating input score 2; 2nd percentile among comparable filings
• Officer compensation ratio: 11%; rating input score 27; 27th percentile among comparable filings

Growth

• Program expense growth: 5.2% per year; rating input score 100; 40th percentile among comparable filings
• Revenue growth: 5% per year; rating input score 100; 42nd percentile among comparable filings
• Asset growth: 2.3% per year; rating input score 100; 21st percentile among comparable filings